What’s New!
When Large-Language-Models Make Sense: A Game Changer for Enterprises
At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, achieved a key milestone of powering over 200 million IOT devices earlier this year.
Inari Raises $89 Million to Bring Innovative, Disruptive Technologies to Growers
CAMBRIDGE, MASS. – August 6, 2019 — Inari, the next-generation seed company, today announced the closing of its $89 million Series C financing, bringing the company’s total funding to date to $144 million.
- 6 Aug 2019
Government-linked strategic investor and leading Silicon Valley investor to Fund Circles.Life Global Ambitions
The latest round came after Circles.Life’s successfully growing subscribers by more than 9X from Q1 2017 to Q1 2019.
- 6 Jun 2019
Biofourmis Closes USD35M Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform Funding
Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform
- 21 May 2019
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
- 22 Apr 2019
ShopBack raises USD45M to power smarter purchase decisions for Asia Pacific consumers
Singapore, 10 April 2019 – ShopBack , the one-stop rewards and discovery platform, has secured US$45M in its latest funding round. New investors include co-leads EV Growth and Rakuten Capital, as well as EDBI, a government-linked strategic investor, along with other existing investors.
- 10 Apr 2019
EDBI continuing to invest in exciting digital health, biotech and fintech companies in Q4 2019
Q4 2019 saw EDBI continuing to invest in exciting digital health, biotech and
fintech companies which would aid our local companies in their digitalisation and
transformation journey.
- 4 Apr 2019
Zilingo has raised USD226M in Series D Funding
Zilingo has raised US$ 226M in Series D financing from Sequoia Capital, Temasek, Burda Principal Investments, Sofina, Singapore investment fund EDBI and existing investors, bringing the total funds raised by the company to US$ 308M.
- 12 Feb 2019
Livongo Signs Definitive Agreement to Acquire myStrength to Address Behavioral Health Needs for People with Chronic Conditions
Livongo Signs Definitive Agreement to Acquire myStrength to Address Behavioral Health Needs for People with Chronic Conditions
- 30 Jan 2019
Pindrop Launches Voice Identity Platform for IoT, Voice Assistants, Smart Homes and Offices, and Connected Cars
Pindrop Extends Enterprise-Grade Identity Technology to Voice-Enabled Consumer and Enterprise Devices as the Trusted Form of Authentication
- 8 Jan 2019
PEAR THERAPEUTICS COMPLETES $64M SERIES C FINANCING
Boston, January 4, 2019 – Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that it has successfully closed a $64 million Series C financing led by Temasek, and joined by other existing investors including Novartis, 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, The Bridge Builders Collaborative, and Singapore-based EDBI.
- 4 Jan 2019
